Vicarious Surgical Inc. (RBOT)
| Market Cap | 273.17K -99.3% |
| Revenue (ttm) | n/a |
| Net Income | -42.12M |
| EPS | -6.55 |
| Shares Out | 7.13M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 190,906 |
| Open | 0.0400 |
| Previous Close | 0.037596 |
| Day's Range | 0.0300 - 0.0400 |
| 52-Week Range | 0.0300 - 7.7250 |
| Beta | 1.92 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Nov 9, 2026 |
About Vicarious Surgical
Vicarious Surgical Inc. engages in the development and sale of single-port surgical robot in the United States. The company offers Vicarious Surgical System, a single-port surgical robot that virtually transports surgeons inside the patient to perform invasive surgery. Vicarious Surgical Inc. was founded in 2014 and is headquartered in Waltham, Massachusetts. [Read more]
Financial Performance
Financial StatementsNews
Vicarious Surgical Proxy statement: Proxy filing
Vicarious Surgical filed a proxy statement on June 22, 2026, providing details for shareholder voting and corporate governance matters.
Vicarious Surgical Proxy statement: Proxy filing
Vicarious Surgical filed a proxy statement on June 12, 2026, providing details for shareholder voting and corporate governance matters.
Vicarious Surgical Demonstrates Sustained System Performance and Complex Hernia Procedure Workflows in Pre-Clinical Setting
WALTHAM, Mass., May 13, 2026 (GLOBE NEWSWIRE) -- Vicarious Surgical Inc. (OTCQB: RBOT), a next-generation robotics technology company seeking to transform minimally invasive surgery (the “Company”), t...
Vicarious Surgical Quarterly report: Q1 2026
Vicarious Surgical has published its Q1 2026 quarterly earnings report on April 30, 2026.
Vicarious Surgical Earnings release: Q1 2026
Vicarious Surgical released its Q1 2026 earnings on April 30, 2026, summarizing the period's financial results.
Vicarious Surgical Reports First Quarter 2026 Financial Results
WALTHAM, Mass., April 30, 2026 (GLOBE NEWSWIRE) -- Vicarious Surgical Inc. (“Vicarious Surgical” or the “Company”) (OTCQB: RBOT), a next-generation robotics technology company seeking to improve lives...
Vicarious Surgical Completes Integrated Benchtop Testing of Full Surgical Instrument Suite for Ventral Hernia Repair
WALTHAM, Mass., March 30, 2026 (GLOBE NEWSWIRE) -- Vicarious Surgical Inc. (OTCQB: RBOT), a next-generation robotics technology company seeking to transform minimally invasive surgery (the “Company”),...
Vicarious Surgical Begins Quotation on the OTCQB as Part of Strategic Path Toward Potential Nasdaq Listing
WALTHAM, Mass., March 25, 2026 (GLOBE NEWSWIRE) -- Vicarious Surgical Inc. (OTCQB: RBOT), a next-generation robotics technology company seeking to transform minimally invasive surgery (the “Company”),...
Vicarious Surgical Proxy statement: Proxy filing
Vicarious Surgical filed a proxy statement on March 23, 2026, providing details for shareholder voting and corporate governance matters.
Vicarious Surgical announces plan to pursue Nasdaq listing
Vicarious Surgical (RBOT) announced a series of strategic actions to support a potential relisting of its common stock on a national exchange. The company said, “Over the past several months,…
Vicarious Surgical Announces Strategic Plan to Pursue Nasdaq Listing
WALTHAM, Mass.--(BUSINESS WIRE)--Vicarious Surgical Inc. (OTCID: RBOT), a next-generation robotics technology company seeking to transform minimally invasive surgery, today announced a series of strat...
Vicarious Surgical Proxy statement: Proxy Filing
Vicarious Surgical filed a proxy statement on March 13, 2026, providing details for shareholder voting and corporate governance matters.
Vicarious Surgical Reports Fourth Quarter and Full Year 2025 Financial Results
WALTHAM, Mass.--(BUSINESS WIRE)--Vicarious Surgical Inc. (“Vicarious Surgical” or the “Company”) (OTCID: RBOT), a next-generation robotics technology company seeking to improve lives by transforming r...
Vicarious Surgical Earnings release: Q4 2025
Vicarious Surgical released its Q4 2025 earnings on March 9, 2026, summarizing the period's financial results.
Vicarious Surgical Annual report: Q4 2025
Vicarious Surgical has published its Q4 2025 annual report on March 9, 2026.
Vicarious Surgical receives delisting notice from NYSE
Vicarious Surgical (RBOT) announced that it received a notice from the NYSE that the NYSE has commenced the process of delisting the company’s Class A common stock, par value $0.0001…
Vicarious Surgical Receives Delisting Notice From NYSE
WALTHAM, Mass.--(BUSINESS WIRE)--Vicarious Surgical Inc. (NYSE: RBOT) (the “Company”), a next-generation robotics technology company seeking to improve lives by transforming robotic surgery, today ann...
NYSE to begin delisting procedures against Vicarious Surgical
The New York Stock Exchange announced that it will commence delisting procedures against Vicarious Surgical (RBOT).
NYSE to Commence Delisting Proceedings Against Vicarious Surgical Inc. (RBOT)
NEW YORK--(BUSINESS WIRE)--The New York Stock Exchange (“NYSE”, the “Exchange”) announced today that the staff of NYSE Regulation has determined to commence proceedings to delist the Class A common st...
Vicarious Surgical Advances Toward Design Freeze with Successful In-Vivo Porcine Lab
WALTHAM, Mass.--(BUSINESS WIRE)--Vicarious Surgical (NYSE: RBOT) (the “Company”), a next-generation robotics technology company seeking to improve lives by transforming robotic surgery, today announce...
Vicarious Surgical announces software partnership to streamline operations
Vicarious Surgical (RBOT) announced that it has entered into a strategic partnership agreement with a global digital engineering and software development services firm. Under the agreement, the extern...
Vicarious Surgical Announces Strategic Software Execution Partnership to Streamline Operations
WALTHAM, Mass.--(BUSINESS WIRE)--Vicarious Surgical Inc. (NYSE: RBOT) (the “Company”), a next-generation robotics technology company seeking to improve lives by transforming robotic surgery, today ann...
NYSE to Commence Delisting Proceedings with Respect to Warrants of Vicarious Surgical Inc. (RBOT WS)
NEW YORK--(BUSINESS WIRE)--The New York Stock Exchange (“NYSE”, the “Exchange”) announced today that the staff of NYSE Regulation has determined to commence proceedings to delist the warrants (“Warran...
Vicarious Surgical Proxy statement: Proxy Filing
Vicarious Surgical filed a proxy statement on December 16, 2025, providing details for shareholder voting and corporate governance matters.
Vicarious Surgical Announces Full Year 2026 Cash Burn Guidance
WALTHAM, Mass.--(BUSINESS WIRE)--Vicarious Surgical Inc. (NYSE: RBOT, RBOT.WS) (the “Company”), a next-generation robotics technology company seeking to improve lives by transforming robotic surgery, ...